All Stories

  1. pyDarwin: A Machine Learning Enhanced Automated Nonlinear Mixed‐Effect Model Selection Toolbox

    Article • Clinical Pharmacology & Therapeutics, January 2024, Wiley

    Kristin Bigos

  2. COVID-19 Infection and Risk for Neuropsychiatric Symptoms

    Article • Biological Psychiatry, October 2022, Elsevier

    Kristin Bigos

  3. A population pharmacokinetic model based on HPTN 077 of long‐acting injectable cabotegravir for HIV PrEP

    Article • British Journal of Clinical Pharmacology, August 2022, Wiley

    Kristin Bigos

  4. Molecular Imaging of the Serotonin Transporter Availability and Occupancy by Antidepressant Treatment in Late-Life Depression

    Article • Neuropharmacology, January 2021, Elsevier

    Dr Clifford Ian Workman, Kristin Bigos

  5. Association of Missense Mutation in FOLH1 With Decreased NAAG Levels and Impaired Working Memory Circuitry and Cognition

    Article • American Journal of Psychiatry, December 2020, American Psychiatric Association

    Kristin Bigos

  6. Nimodipine improves cortical efficiency during working memory in healthy subjects

    Article • Translational Psychiatry, November 2020, Springer Science + Business Media

    Kristin Bigos

  7. Invited Perspective on Pharmacogenetics in Late-Life Depression

    Article • American Journal of Geriatric Psychiatry, June 2020, Elsevier

    Kristin Bigos

  8. Differential Response to Risperidone in Schizophrenia Patients by KCNH2 Genotype and Drug Metabolizer Status

    Article • American Journal of Psychiatry, January 2016, American Psychiatric Association

    Kristin Bigos

  9. Differential Effects of Common Variants inSCN2Aon General Cognitive Ability, Brain Physiology, and messenger RNA Expression in Schizophrenia Cases and Control Individuals

    Article • JAMA Psychiatry, June 2014, American Medical Association (AMA)

    Kristin Bigos

  10. Response to Warner Letter

    Article • American Journal of Psychiatry, December 2012, American Psychiatric Association

    Kristin Bigos

  11. Genetic Variation in KCNH2 Associated With Expression in the Brain of a Unique hERG Isoform Modulates Treatment Response in Patients With Schizophrenia

    Article • American Journal of Psychiatry, July 2012, American Psychiatric Association

    Kristin Bigos

  12. Genetic variation in CYP3A43 explains racial difference in olanzapine clearance

    Article • Molecular Psychiatry, April 2011, Springer Science + Business Media

    Kristin Bigos

  13. Imaging genetics—days of future past

    Article • NeuroImage, November 2010, Elsevier

    Kristin Bigos

  14. Genetic Variation in CACNA1C Affects Brain Circuitries Related to Mental Illness

    Article • Archives of General Psychiatry, September 2010, American Medical Association (AMA)

    Kristin Bigos

  15. Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: An updated review

    Article • Gender Medicine, December 2009, Elsevier

    Kristin Bigos

  16. Dysregulation of neurosteroids in obsessive compulsive disorder

    Article • Journal of Psychiatric Research, January 2009, Elsevier

    Kristin Bigos

  17. Suboptimal Aminoglycoside Dosing in Critically Ill Patients

    Article • Therapeutic Drug Monitoring, December 2008, Wolters Kluwer Health

    Kristin Bigos

  18. Acute 5-HT Reuptake Blockade Potentiates Human Amygdala Reactivity

    Article • Neuropsychopharmacology, May 2008, Springer Science + Business Media

    Kristin Bigos

  19. Pharmacokinetics in geriatric psychiatry

    Article • Current Psychiatry Reports, February 2008, Springer Science + Business Media

    Kristin Bigos

  20. Sex, Race, and Smoking Impact Olanzapine Exposure

    Article • The Journal of Clinical Pharmacology, February 2008, Wiley

    Kristin Bigos

  21. Neuroimaging: Technologies at the Interface of Genes, Brain, and Behavior

    Article • Neuroimaging Clinics of North America, November 2007, Elsevier

    Kristin Bigos

  22. Population Pharmacokinetics in Geriatric Psychiatry

    Article • American Journal of Geriatric Psychiatry, December 2006, Elsevier

    Kristin Bigos

  23. Decreasing Pain and Anxiety Associated with Patient‐Activated Atrial Shock: A Placebo‐Controlled Study of Adjunctive Sedation with Oral Triazolam

    Article • Journal of Cardiovascular Electrophysiology, February 2006, Wiley

    Kristin Bigos

  24. Influence of DHEA Administration on 24-Hour Cortisol Concentrations

    Article • Journal of Clinical Psychopharmacology, February 2003, Wolters Kluwer Health

    Kristin Bigos

  25. The Influence of Hormones and Pharmaceutical Agents on DHEA and DHEA‐S Concentrations: A Review of Clinical Studies

    Article • The Journal of Clinical Pharmacology, March 2002, Wiley

    Kristin Bigos